Study examines challenges in integrating psilocybin therapy with palliative care

Coryn Mayer says the healthcare system needs to improve if psilocybin therapy is to become a mainstream tool.


Vancouver’s Havn Life announces first psilocybin mushroom harvest in Jamaica

Vancouver biotechnology company Havn Life will export yield to UBC-based Delic Labs for quality control and testing.

psychedelic products, Numinus, Numinus Wellness

Numinus subsidiary files U.S. patent application for rapid production of psychedelic treatments

The Vancouver-based company has a licence from Health Canada to test, sell, and distribute psychedelic substances.


Psychedelics researcher explains why a bad trip is a good one after all

Petter Grahl Johnstad of the University of Bergen says a bad psychedelics trip can be a way to confront personal demons.


Cybin Inc. announces revolutionary study of ketamine with neuroimaging helmet

Toronto-based Cybin plans to look at real time effects of ketamine on the brain.


Psychedelics linked to better mental health amid COVID-19 pandemic

A study in Argentina finds association between the use of psychedelic substances with positive mental health outcomes.